Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

ERManI is a target of miR-125b and promotes transformation phenotypes in hepatocellular carcinoma (HCC).

Pan S, Cheng X, Chen H, Castro PD, Ittmann MM, Hutson AW, Zapata SK, Sifers RN.

PLoS One. 2013 Aug 5;8(8):e72829. doi: 10.1371/journal.pone.0072829. Print 2013.

PMID:
23940818
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer.

Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, Stokes A, Francis T, Hughart N, Hubble L, Zhuang SM, Meng F.

J Hepatol. 2011 Dec;55(6):1339-45. doi: 10.1016/j.jhep.2011.04.015. Epub 2011 May 19.

PMID:
21703189
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3.

Xu G, Zhang Y, Wei J, Jia W, Ge Z, Zhang Z, Liu X.

BMC Cancer. 2013 Oct 10;13:469. doi: 10.1186/1471-2407-13-469.

PMID:
24112539
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.

Fan DN, Tsang FH, Tam AH, Au SL, Wong CC, Wei L, Lee JM, He X, Ng IO, Wong CM.

Hepatology. 2013 Feb;57(2):637-47. doi: 10.1002/hep.26083. Epub 2012 Dec 6.

PMID:
22991213
[PubMed - indexed for MEDLINE]
5.

Cyclooxygenase-2 is a target of microRNA-16 in human hepatoma cells.

Agra Andrieu N, Motiño O, Mayoral R, Llorente Izquierdo C, Fernández-Alvarez A, Boscá L, Casado M, Martín-Sanz P.

PLoS One. 2012;7(11):e50935. doi: 10.1371/journal.pone.0050935. Epub 2012 Nov 30.

PMID:
23226427
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.

He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.

Oncogene. 2012 Jul 12;31(28):3357-69. doi: 10.1038/onc.2011.500. Epub 2011 Nov 7.

PMID:
22056881
[PubMed - indexed for MEDLINE]
7.

Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.

Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF.

Ann Surg. 2014 Feb;259(2):346-54. doi: 10.1097/SLA.0000000000000223.

PMID:
24135722
[PubMed - indexed for MEDLINE]
8.

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity.

Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, Wu M, Pan Z, Zhou W.

Br J Cancer. 2010 Oct 12;103(8):1215-20. doi: 10.1038/sj.bjc.6605895. Epub 2010 Sep 14.

PMID:
20842113
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Downregulation of microRNA-100 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.

Chen P, Zhao X, Ma L.

Mol Cell Biochem. 2013 Nov;383(1-2):49-58. doi: 10.1007/s11010-013-1753-0. Epub 2013 Jul 11.

PMID:
23842624
[PubMed - indexed for MEDLINE]
10.

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.

Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y, Zhuang SM.

Cancer Res. 2009 Feb 1;69(3):1135-42. doi: 10.1158/0008-5472.CAN-08-2886. Epub 2009 Jan 20.

PMID:
19155302
[PubMed - indexed for MEDLINE]
Free Article
11.

Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma.

Xu WP, Yi M, Li QQ, Zhou WP, Cong WM, Yang Y, Ning BF, Yin C, Huang ZW, Wang J, Qian H, Jiang CF, Chen YX, Xia CY, Wang HY, Zhang X, Xie WF.

Hepatology. 2013 Dec;58(6):1977-91. doi: 10.1002/hep.26541. Epub 2013 Oct 30.

PMID:
23728999
[PubMed - indexed for MEDLINE]
12.

Modulation of the unfolded protein response is the core of microRNA-122-involved sensitivity to chemotherapy in hepatocellular carcinoma.

Yang F, Zhang L, Wang F, Wang Y, Huo XS, Yin YX, Wang YQ, Zhang L, Sun SH.

Neoplasia. 2011 Jul;13(7):590-600.

PMID:
21750653
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion.

Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G, Beckebaum S.

Mol Cancer. 2010 Aug 27;9:227. doi: 10.1186/1476-4598-9-227.

PMID:
20799954
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.

Lu Y, Yue X, Cui Y, Zhang J, Wang K.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):873-9. doi: 10.1016/j.bbrc.2013.10.157. Epub 2013 Nov 6.

PMID:
24211205
[PubMed - indexed for MEDLINE]
15.

MiR-205 modulates abnormal lipid metabolism of hepatoma cells via targeting acyl-CoA synthetase long-chain family member 1 (ACSL1) mRNA.

Cui M, Wang Y, Sun B, Xiao Z, Ye L, Zhang X.

Biochem Biophys Res Commun. 2014 Feb 7;444(2):270-5. doi: 10.1016/j.bbrc.2014.01.051. Epub 2014 Jan 22.

PMID:
24462768
[PubMed - indexed for MEDLINE]
16.

Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.

Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B.

Gastroenterology. 2012 Sep;143(3):811-20.e1-15. doi: 10.1053/j.gastro.2012.05.033. Epub 2012 May 26.

PMID:
22641068
[PubMed - indexed for MEDLINE]
17.

MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma.

Shi C, Xu X.

Biomed Pharmacother. 2013 Jun;67(5):375-80. doi: 10.1016/j.biopha.2013.03.002. Epub 2013 Mar 24.

PMID:
23582783
[PubMed - indexed for MEDLINE]
18.

VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma.

Liu Y, Hei Y, Shu Q, Dong J, Gao Y, Fu H, Zheng X, Yang G.

PLoS One. 2012;7(4):e35800. doi: 10.1371/journal.pone.0035800. Epub 2012 Apr 20.

PMID:
22536440
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.

Zhu XC, Dong QZ, Zhang XF, Deng B, Jia HL, Ye QH, Qin LX, Wu XZ.

Int J Mol Med. 2012 Dec;30(6):1321-6. doi: 10.3892/ijmm.2012.1140. Epub 2012 Sep 25.

PMID:
23023935
[PubMed - indexed for MEDLINE]
20.

MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.

Lang Q, Ling C.

Biochem Biophys Res Commun. 2012 Sep 21;426(2):247-52. doi: 10.1016/j.bbrc.2012.08.075. Epub 2012 Aug 23.

PMID:
22940133
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk